11 results on '"Jöhrens, Korinna"'
Search Results
2. Prognostic impact of the post-treatment T cell composition and spatial organization in soft tissue sarcoma patients treated with neoadjuvant hyperthermic radio(chemo)therapy.
- Author
-
Rupp, Luise, Resag, Antonia, Potkrajcic, Vlatko, Warm, Verena, Wehner, Rebekka, Jöhrens, Korinna, Bösmüller, Hans, Eckert, Franziska, and Schmitz, Marc
- Subjects
T cells ,SARCOMA ,T helper cells ,COMBINED modality therapy ,PROGNOSIS - Abstract
Soft tissue sarcomas (STS) form a heterogeneous group of tumors sharing a mesenchymal origin. Despite good local control of the disease, the occurrence of distant metastases often limits survival of STS patients with localized, high-risk tumors of the extremities. Accumulating evidence suggests a central role for the tumor immune microenvironment in determining the clinical outcome and response to therapy. Thus, it has been reported that STS patients with a high immune signature and especially presence of B cells and tertiary lymphoid structures display improved overall survival and response to checkpoint inhibitor treatment. Here, we explored the effect of curative multimodal therapy on the T cell landscape of STS using multiplex immunohistochemistry. We analyzed the phenotype, frequency, and spatial distribution of STS-infiltrating CD8
+ T cells by staining for CD8, 4-1BB, Granzyme B, Ki67, PD-1, and LAG-3 as well as CD3+ T helper cells using a panel consisting of CD3, T-bet, GATA3, RORγT, FoxP3, and Ki67. All patients received neoadjuvant radiotherapy plus locoregional hyperthermia with or without chemotherapy. While the treatment-naïve biopsy sample allows an analysis of baseline T cell infiltration levels, both intra- and peritumoral areas of the matched resected tissue were analyzed to assess composition and spatial distribution of the T cell compartment and its therapeutic modulation. Generally, post-treatment tissues displayed lower frequencies of CD3+ and CD8+ T cells. Association with clinical data revealed that higher post-treatment frequencies of peritumoral and intratumoral CD3+ T cells and intratumoral PD-1+ CD8+ T cells were significantly associated with improved disease-free survival (DFS), while these densities had no prognostic significance in the biopsy. Upon spatial analysis, a high ratio of intratumoral to peritumoral CD8+ T cells emerged as an independent prognostic marker for longer DFS. These results indicate that the STS T cell landscape is altered by multimodal therapy and may influence the clinical outcome of patients. An enhanced understanding of the STS immune architecture and its modulation by neoadjuvant therapy may pave the way towards novel treatment modalities and improve the long-term clinical outcome of STS patients. [ABSTRACT FROM AUTHOR]- Published
- 2023
- Full Text
- View/download PDF
3. T-cell repertoires in refractory coeliac disease.
- Author
-
Ritter, Julia, Zimmermann, Karin, Jöhrens, Korinna, Mende, Stefanie, Seegebarth, Anke, Siegmund, Britta, Hennig, Steffen, Todorova, Kremena, Rosenwald, Andreas, Daum, Severin, Hummel, Michael, and Schumann, Michael
- Subjects
CELIAC disease ,T cells ,T-cell receptor genes ,NUCLEOTIDE sequencing ,IMMUNOHISTOCHEMISTRY ,GENE rearrangement ,DUODENUM - Published
- 2018
- Full Text
- View/download PDF
4. Increase of T and B cells and altered BACH2 expression patterns in bone marrow trephines of imatinib-treated patients with chronic myelogenous leukaemia.
- Author
-
VON LAFFERT, MAXIMILIAN, HÄNEL, MATHIAS, DIETEL, MANFRED, ANAGNOSTOPOULOS, IOANNIS, and JÖHRENS, KORINNA
- Subjects
B cells ,T cells ,IMATINIB ,BONE marrow ,CHRONIC myeloid leukemia - Abstract
The effect of imatinib on T and B cells in patients with chronic myelogenous leukaemia (CML) is not well understood. An upregulation of the transcription factor Broad-complex-Tramtrack-Bric-a-Brac and Cap'n'collar 1 bZip transcription factor 2 (BACH2), which is involved in the development and differentiation of B cells, was demonstrated in a CML cell line treated with imatinib. The present study retrospectively analysed the expression and distribution of cluster of differentiation (CD)3, CD20 and BACH2 (per 1,000 cells), as well as the co-expression of CD20 and BACH2, using immunohistochemistry in serial bone marrow trephines obtained from 14 CML patients treated with imatinib in comparison to 17 patients with newly diagnosed CML and 6 control trephines. Bone marrow trephines of CML patients in remission under imatinib therapy exhibited significantly higher numbers of CD3 and CD20 infiltrates (partly ordered in aggregates) compared with patients with newly diagnosed CML and control individuals. Similarly, nuclear expression of BACH2 in granulopoietic cells was increased in CML patients treated with imatinib, which may represent the histological correlate of the positive treatment effect. Furthermore, since BACH2 is involved in B cell development, its altered expression patterns by imatinib may be one explanation for high B cell numbers, as revealed by CD20/BACH2 (nuclear)-positive cells. As the present data are preliminary, future prospective studies are required to assess the prognostic and predictive role of BACH2 in patients with CML under targeted therapy. [ABSTRACT FROM AUTHOR]
- Published
- 2016
- Full Text
- View/download PDF
5. Bone marrow T-cell infiltration during acute GVHD is associated with delayed B-cell recovery and function after HSCT.
- Author
-
Mensen, Angela, Jöhrens, Korinna, Anagnostopoulos, Johrens, Demski, Sonya, Oey, Maike, Stroux, Andrea, Hemmati, Philipp, Westermann, Jörg, Blau, Olga, Wittenbecher, Friedrich, Movassaghi, Kamran, Szyska, Martin, Thomas, Sybill, Dörken, Bernd, Scheibenbogen, Carmen, Arnold, Renate, and Na, ll-Kang
- Subjects
- *
GRAFT versus host disease , *BONE marrow , *T cells , *LYMPHOCYTES , *POLYMERASE chain reaction - Abstract
B-cell immune dysfunction contributes to the risk of severe infections after allogeneic hematopoietic stem cell transplantation (allo-HSCT). Delayed B-cell regeneration is found in patients with systemic graft-versus-host disease (GVHD) and is often accompanied by bone marrow (BM) suppression. Little is known about human BM GVHD. We analyzed the reconstitution kinetics of B-cell subsets in adult leukemic patients within 6 months after allo-HSCT. B-cell deficiency already existed before transplant and was aggravated after transplant. Onset of B-cell reconstitution characterized by transitional B-cell recovery occurred either early (months 2-3) or late (from month 6 on) and correlated highly positively with reverse transcription-polymerase chain reaction quantified numbers of K-deleting recombination excision circles (KRECs). Delayed recovery was associated with systemic acute GVHD and full-intensity conditioning therapy. Histological analysis of BM trephines revealed increased T-cell infiltration in late recovering patients, which was associated with reduced numbers of osteoblasts. Functionally, late recovering patients displayed less pneumococcal polysaccharide-specific immunoglobin M-producing B cells on ex vivo B-cell activation than early recovering patients. Our results provide evidence for acute BM GVHD in allo-HSCT patients with infiltrating donor T cells and osteoblast destruction. This is associated with delayed B-cell reconstitution and impaired antibody response. Herein, KREC appears suitable to monitor BM B-cell output after transplant. [ABSTRACT FROM AUTHOR]
- Published
- 2014
- Full Text
- View/download PDF
6. Three different expression patterns of T-bet in angioimmunoblastic T-cell lymphoma.
- Author
-
Jöhrens, Korinna, Dietel, Manfred, and Anagnostopoulos, Ioannis
- Subjects
- *
T-cell lymphoma , *TRANSCRIPTION factors , *DISEASE progression , *IMMUNE response , *T cells - Abstract
Angioimmunoblastic T-cell lymphoma (AITL) exhibits a multifaceted clinical picture and distinct architectural patterns that correlate with disease progression and the number of neoplastic cells. In this study we investigated the expression of the transcription factor T-bet and correlated it with the architectural patterns in 29 cases of AITL. Double immunolabelings for T-bet, CD20, CD3 or PD1 revealed the following patterns: predominant T-bet expression by neoplastic T-cells (A), by aggregates of small B-cells (B) or by B-immunoblasts (C). The majority of cases of AITL pattern II showed a T-bet expression pattern B (6/8 cases), while the majority of those with pattern III exhibited the T-bet pattern A (11/21 cases). We propose that T-bet expression by B-cells represents a T-cell independent immune response trying to cope with opportunistic infections, while T-bet expression by neoplastic T-cells is linked to the introduction of a Th17 response responsible for the immunologic derangements characteristic of AITL. [ABSTRACT FROM AUTHOR]
- Published
- 2012
- Full Text
- View/download PDF
7. T-box-expressed-in-T-cells (T-bet) expression by the tumor cells of hairy cell leukemia correlates with interferon-γ production.
- Author
-
Jöhrens, Korinna, Moos, Verena, Schneider, Thomas, and Anagnostopoulos, Ioannis
- Subjects
- *
HAIRY cell leukemia , *B cells , *CARCINOGENESIS , *T cells , *INTERFERONS - Abstract
Hairy cell leukemia (HCL) is an uncommon B-cell malignancy with unknown pathogenesis. In an earlier study, we demonstrated that HCL cells highly express the transcription factor T-box-expressed-in-T-cells (T-bet). T-bet is the master regulator of the T-helper (Th)1 cell response regulating interferon gamma (IFN-γ) production and also plays a central role in the T-cell independent Th1-like B-cell response. Here, we demonstrate by fluorescence activated cell sorting (FACS) analysis that neoplastic cells from the peripheral blood of five patients with HCL showed an enhanced expression of IFN-γ after stimulation. Additionally, a comparison with 55 healthy individuals revealed a significant elevation of IFN-γ in the sera of patients with HCL. Based on our recent findings that a non-neoplastic B-cell subset, the monocytoid B-cells, are T-bet positive and produce IFN-γ, we propose that monocytoid and hairy B-cells have a similar function and that the T-bet-IFN-γ axis is involved in the pathogenesis of HCL. [ABSTRACT FROM AUTHOR]
- Published
- 2009
- Full Text
- View/download PDF
8. Gene deregulation and spatial genome reorganization near breakpoints prior to formation of translocations in anaplastic large cell lymphoma.
- Author
-
Mathas, Stephan, Kreher, Stephan, Meaburn, Karen J., Jöhrens, Korinna, Lamprecht, Björn, Assaf, Chalid, Sterry, Wolfram, Kadin, Marshall E., Daibata, Masanori, Joos, Stefan, Hummel, Michael, Stein, Harald, Janz, Martin, Anagnostopoulos, Ioannis, Schrock, Evelin, Misteli, Tom, and Dörken, Bernd
- Subjects
GENETIC regulation ,GENOMES ,LYMPHOMAS ,T cells ,TRANSCRIPTION factors ,PROTEIN-tyrosine kinases - Abstract
Although the identification and characterization of translocations have rapidly increased, little is known about the mechanisms of how translocations occur in vivo. We used anaplastic large cell lymphoma (ALCL) with and without the characteristic t(2;5)(p23;q35) translocation to study the mechanisms of formation of translocations and of ALCL transformation. We report deregulation of several genes located near the ALCL translocation breakpoint, regardless of whether the tumor contains the t(2;5). The affected genes include the oncogenic transcription factor Fra2 (located on 2p23), the HLH protein Id2 (2p25), and the oncogenic tyrosine kinase CSF1-receptor (5q33.1). Their up-regulation promotes cell survival and repression of T cell-specific gene expression programs that are characteristic for ALCL. The deregulated genes are in spatial proximity within the nuclear space of t(2;5)-negative ALCL cells, facilitating their translocation on induction of double-strand breaks. These data suggest that deregulation of breakpoint-proximal genes occurs before the formation of translocations, and that aberrant transcriptional activity of genomic regions is linked to their propensity to undergo chromosomal translocations. Also, our data demonstrate that deregulation of breakpoint-proximal genes has a key role in ALCL. [ABSTRACT FROM AUTHOR]
- Published
- 2009
- Full Text
- View/download PDF
9. Immunoprofiling in Neuroendocrine Neoplasms Unveil Immunosuppressive Microenvironment.
- Author
-
Busse, Antonia, Mochmann, Liliana H., Spenke, Christiane, Arsenic, Ruza, Briest, Franziska, Jöhrens, Korinna, Lammert, Hedwig, Sipos, Bence, Kühl, Anja A., Wirtz, Ralph, Pavel, Marianne, Hummel, Michael, Kaemmerer, Daniel, Baum, Richard P., and Grabowski, Patricia
- Subjects
CHEMOKINES ,IMMUNOGLOBULINS ,IMMUNOHISTOCHEMISTRY ,IMMUNOPHENOTYPING ,IMMUNOSUPPRESSION ,MEMBRANE proteins ,MESSENGER RNA ,NEUROENDOCRINE tumors ,T cells ,CANCER genes ,GENE expression profiling ,DESCRIPTIVE statistics - Abstract
Simple Summary: Immunotherapy with checkpoint inhibitors targeting the programmed cell death protein 1 (PD-1)/programmed death-ligand 1 (PD-L1) axis or Cytotoxic T-lymphocyte-associated protein 4 (CTLA-4) has shown only modest activity in neuroendocrine tumors (NET) and neuroendocrine carcinomas (NEC). By investigating the tumor immune microenvironment in NET/NEC with immunohistochemistry (IHC) and mRNA immunoprofiling, we found that they lack signs of an activation of an antitumor immune response like intratumoral T cell infiltration and expression of IFNγ regulated genes. But NET and NEC expressed several immunosuppressive genes. This included chemokines, known to attract immunosuppressive myeloid cells but not antitumor effector cells, or genes with immunosuppressive functions. Some of those might be expressed by both tumor cells and immune cells, such as CD74, and represent potential therapeutic targets for immunomodulation. Checkpoint inhibitors have shown promising results in a variety of tumors; however, in neuroendocrine tumors (NET) and neuroendocrine carcinomas (NEC), low response rates were reported. We aimed herein to investigate the tumor immune microenvironment in NET/NEC to determine whether checkpoint pathways like programmed cell death protein 1 (PD-1)/programmed death-ligand 1 (PD-L1) might play a role in immune escape and whether other escape mechanisms might need to be targeted to enable a functional antitumor response. Forty-eight NET and thirty NEC samples were analyzed by immunohistochemistry (IHC) and mRNA immunoprofiling including digital spatial profiling. Through IHC, both NET/NEC showed stromal, but less intratumoral CD3+ T cell infiltration, although this was significantly higher in NEC compared to NET. Expression of PD1, PD-L1, and T cell immunoglobulin and mucin domain-containing protein 3 (TIM3) on immune cells was low or nearly absent. mRNA immunoprofiling revealed low expression of IFNγ inducible genes in NET and NEC without any spatial heterogeneity. However, we observed an increased mRNA expression of chemokines, which attract myeloid cells in NET and NEC, and a high abundance of genes related to immunosuppressive myeloid cells and genes with immunosuppressive functions like CD47 and CD74. In conclusion, NET and NEC lack signs of an activation of the adaptive immune system, but rather show abundance of several immunosuppressive genes that represent potential targets for immunomodulation. [ABSTRACT FROM AUTHOR]
- Published
- 2020
- Full Text
- View/download PDF
10. Non-mediastinal grey zone lymphomas and report from the workshop.
- Author
-
Stein, Harald, Jöhrens, Korinna, and Anagnostopoulos, Ioannis
- Subjects
- *
LYMPHOMAS , *HODGKIN'S disease , *B cells , *T cells , *TUMORS , *LYMPHOCYTES - Abstract
Stein H, Jöhrens K, Anagnostopoulos I. Non-mediastinal grey zone lymphomas and report from the workshop.Eur J Haematol 2005: 75 (Suppl. 66): 42–44.© Blackwell Munksgaard 2005.Grey zone lymphomas represent borderline lesions between classical Hodgkin lymphoma (cHL) and other morphologically and immunophenotypically related diseases and entities like nodular lymphocyte predominant HL, T-cell rich B-cell lymphoma, ALK-negative anaplastic large cell lymphoma (ALCL), diffuse large B cell lymphoma (DLBCL) anaplastic variant and primary mediastinal LBCL. The sharp definition of morphological, immunophenotypical and molecular features of the‘‘text-book cases’’ of each disease and the comparison with grey zone cases has reduced most of the latter cases. Two reports in this workshop dealt with the problematic non-mediastinal grey zone lymphomas, one with a cHL of T cell-type presenting in the skin as a ALK-negative ALCL and the other with the grey zone between cHL of B-cell type and ALK-negative ALCL. [ABSTRACT FROM AUTHOR]
- Published
- 2005
- Full Text
- View/download PDF
11. Cytotoxic tumour-infiltrating T lymphocytes influence outcome in resected pancreatic ductal adenocarcinoma.
- Author
-
Lohneis, Philipp, Sinn, Marianne, Bischoff, Sven, Jühling, Anja, Pelzer, Uwe, Wislocka, Lilianna, Bahra, Marcus, Sinn, Bruno V., Denkert, Carsten, Oettle, Helmut, Bläker, Hendrik, Riess, Hanno, Jöhrens, Korinna, and Striefler, Jana K.
- Subjects
- *
ADENOCARCINOMA , *ANTIMETABOLITES , *IMMUNOHISTOCHEMISTRY , *PANCREATIC tumors , *PROGNOSIS , *SURVIVAL , *T cells , *DUCTAL carcinoma , *TISSUE arrays , *DESCRIPTIVE statistics - Abstract
Background We studied the prognostic effect of CD3-, CD8- and CD103-positive T lymphocytes in a cohort of 165 patients with resected pancreatic ductal adenocarcinomas (PDACs) of the treatment group (adjuvant gemcitabine) and the untreated control group of the CONKO-001 study. Methods Immunohistochemical stainings on tissue microarrays (TMAs) against CD3, CD8 and CD103 were performed according to standard procedures. Results A high number of CD8-positive lymphocytes were significantly and independently associated with longer disease-free survival (DFS) and overall survival (OS) in the overall study population. Median DFS/OS were 7.4/18.1 months for patients with a low number of CD8-positive intratumoural lymphocytes ( ≤ 42 per 1 mm tissue core) and 12.7/25.2 months for patients with high numbers (>42 per 1-mm tissue core; p = 0.008/0.020; HR 0.62/0.65). The ratio of intraepithelial to total CD103-positive lymphocytes, but not total numbers of CD103-positive lymphocytes or CD103-positive intraepithelial lymphocytes, was associated with significantly improved DFS and OS in the overall study population (p = 0.022/0.009). Median DFS/OS was 5.9/15.7 for patients with a ratio of intraepithelial to total CD103-positive intratumoural lymphocytes higher than 0.3 and 11.6/24.7 for patients with a lower ratio. Conclusion T-lymphocyte subpopulations might be prognostic in resectable PDAC but need standardization and verification by further studies. [ABSTRACT FROM AUTHOR]
- Published
- 2017
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.